Treatment Options: Monitoring vs. Removal

Once a diagnosis of intraductal breast papillomatosis is confirmed via biopsy, the next step is deciding how to manage it. Because these growths are benign, “treatment” doesn’t always mean surgery. Instead, you and your doctors will weigh the risk of the biopsy having missed an adjacent high-risk lesion (the upgrade rate) against the benefits, risks, and recovery of a procedure ^[1][2].

The Decision Framework

The choice between active surveillance (observation with imaging) and excision (removal) is guided by your specific pathology, imaging results, and the presence of multiple lesions. The criteria below are factors for individualized management, not hard universal rules.

When Surveillance is an Option

Active surveillance may be considered appropriate if your case meets “low-risk” criteria:

• No Atypia: The cells look completely normal under the microscope ^[1].
• Concordance: Your multidisciplinary team agrees that the biopsy perfectly explains what they saw on your imaging ^[3][4].
• Asymptomatic: The growths are not causing distressing nipple discharge or a felt mass ^[3].
• Lesion Size & Multiplicity: Smaller lesions without suspicious features may be monitored ^[5][4].

For specific cohorts of patients with a strictly concordant, asymptomatic benign papilloma, the risk of finding cancer later (the underestimation rate) is low, estimated at 1.4% to 1.7% in published studies ^[2][3]. Surveillance usually involves follow-up imaging (matching the modality that found the lesion) every 6 to 12 months for a period of time to ensure the area remains stable ^[6][7].

When Excision is Recommended

Your care team will likely recommend removing the papillomas if “high-risk” features are present, suggesting a higher chance that the small biopsy missed a more serious change nearby:

• Presence of Atypia: If the biopsy shows atypia like ADH, the upgrade rate to carcinoma can jump to 20% to 36% in meta-analyses ^[8][9]. Excision is generally standard here.
• Discordance: If the imaging looks suspicious but the biopsy says “benign,” the results are discordant. Discordance generally warrants repeat sampling or excision; one cohort study found a 50% upgrade rate for discordant lesions ^[4].
• Other Clinical Factors: Features like larger size (e.g., >10-15 mm), persistent bloody discharge, or older age are often factors favoring excision based on local protocols ^[4][10].

Treatment Options: Risks and Recovery

1. Vacuum-Assisted Excision (VAE)

This is a procedure performed by a radiologist using local numbing. A specialized, larger needle uses a vacuum to pull the tissue into the needle and remove it.

• Pros: Avoids open surgery and general anesthesia. Leaves only a skin puncture mark, with a faster recovery time ^[11].
• Cons: VAE is appropriate only for selected lesions. It can leave a hematoma (bruising/bleeding) and cause pain. It may not completely remove the lesion; studies note a residual tissue/regrowth rate of about 7.7% ^[12]. It may not provide sufficient management for atypia or discordance.

2. Open Surgical Excision

This is a traditional surgery performed by a breast surgeon, usually under sedation or general anesthesia, to remove the targeted tissue.

• Pros: Provides the most complete tissue sample for the pathologist, which is critical if atypia or discordance is present ^[8][13].
• Cons: Requires a surgical incision. Risks include wound infection, bleeding/hematoma, and anesthesia effects. You will have a scar, possible cosmetic contour changes, and potential alterations in nipple sensation or duct function (which could affect breastfeeding). Recovery usually requires activity restriction and pain management for a few days. With multiple lesions, removing one targeted area may not remove every papilloma in the breast ^[14][12].

The Timeline

Typically, pathology results take a few days to a week. If excision is chosen, follow-up to check wound healing is usually scheduled within a few weeks, and subsequent surveillance imaging will be planned based on those final pathology results.